laparoscopic sleeve gastrectomy (SG)	Roux-en-Y gastric bypass (RYGB) procedure	Glycated hemoglobin A1c (HbA1c)	10004	10388	Primary and secondary outcomes at 36 months are shown in Table 2. 22 patients (78.6 %) in SG group and 23 patients (85.2 %) in RYGB group achieved complete remission of diabetes mellitus with HbA1c < 6.0 % (P = 0.525) and without taking antidiabetic medications, and 25 patients in each group (89.3 % vs. 92.6 %) gained successful treatment of diabetes with HbA1c â‰¤ 6.5 % (P = 0.100).
laparoscopic sleeve gastrectomy (SG)	Roux-en-Y gastric bypass (RYGB) procedure	Glycated hemoglobin A1c (HbA1c)	955	1124	At the end point, 22 patients (78.6 %) in SG group and 23 patients (85.2 %) in RYGB group achieved complete remission of diabetes mellitus with HbA1c < 6.0 % (P = 0.525)
laparoscopic sleeve gastrectomy (SG)	Roux-en-Y gastric bypass (RYGB) procedure	HbA1c, FBG and C peptid	1286	1355	Change in HbA1c, FBG and C peptide were comparable in the two groups.
